MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial-mesenchymal transition

MLA

Xiaoyan Chen, et al. “MYLK Promotes Hepatocellular Carcinoma Progression through Regulating Cytoskeleton to Enhance Epithelial-Mesenchymal Transition.” Clinical and Experimental Medicine, vol. 18, no. 4, Dec. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3d89c89fa0ad6ed5175294f6cdb62522&authtype=sso&custid=ns315887.

APA

Xiaoyan Chen, Wansong Lin, Jie Lin, Lingfeng. Chen, Yihui He, & Shengbing Zang. (2017). MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial-mesenchymal transition. Clinical and Experimental Medicine, 18(4).

Chicago

Xiaoyan Chen, Wansong Lin, Jie Lin, Lingfeng. Chen, Yihui He, and Shengbing Zang. 2017. “MYLK Promotes Hepatocellular Carcinoma Progression through Regulating Cytoskeleton to Enhance Epithelial-Mesenchymal Transition.” Clinical and Experimental Medicine 18 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3d89c89fa0ad6ed5175294f6cdb62522&authtype=sso&custid=ns315887.